U
MDVL

UBS’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

UBS’s Portfolio MDVL Stock Details MDVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$7K Buy
+1
New +$8.61K ﹤0.01% 9193

Other funds holding MDVL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS's MDVL Position: Q3 2014 in Review

UBS opened a new position in MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2014: 1 share worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #9193 among its holdings.

8 funds tracked by Wall St. Rank hold MDVL as of Q3 2014.

  • UBS held 1 share of MedAvail Holdings, Inc. Common Stock worth $7K as of Q3 2014.
  • MedAvail Holdings, Inc. Common Stock was a new UBS position in Q3 2014.
  • MedAvail Holdings, Inc. Common Stock made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9193 holding.
  • 8 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.